These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1838031)

  • 1. Normal response to anti-HBV vaccination in children with chronic renal insufficiency.
    La Manna A; Polito C; Foglia AC; Opallo A; Cafaro MR; Di Toro R
    Child Nephrol Urol; 1991; 11(4):203-5. PubMed ID: 1838031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B vaccination in dialysis patients: reversibility of defective immune response by simultaneous administration of interleukin 2].
    Zeitz M
    Z Gastroenterol; 1990 Mar; 28(3):179-80. PubMed ID: 2140478
    [No Abstract]   [Full Text] [Related]  

  • 6. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of immunocompromised condition in the prophylaxis of hepatitis B in chronic renal insufficiency.
    Gasparović V; Puljević D; Gjurasin M; Delimar N; Borcić D; Gasparović H; Mihaljević I
    Acta Med Croatica; 1993; 47(2):61-5. PubMed ID: 7505130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal response to hepatitis B vaccine in drug users.
    Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
    Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of A3 allele in response to hepatitis B vaccine in end-stage renal disease patients.
    Ozdemir FN; Micozkadioglu H; Arat Z; Turan M; Gulmus S; Haberal M
    Transplant Proc; 2004 Nov; 36(9):2615-7. PubMed ID: 15621103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
    Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the response to the recombinant vaccine against hepatitis B virus in dialyzed and nondialyzed children with CRF using different doses and routes of administration.
    Vazquez G; Mendoza-Guevara L; Alvarez T; Aguilar A; Morales A; Rodriguez F; Solorzano F; Garcia-Lopez E; Muñoz O
    Adv Perit Dial; 1997; 13():291-6. PubMed ID: 9360702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.